ArticleThe plant genome2025
A public mid-density genotyping platform for cultivated cranberry (Vaccinium macrocarpon Aiton).
Article in The plant genome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Standardized microhaplotype databases and frameworks for assessing and mining crop genetic diversity.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026Article
- A public mid-density genotyping platform for pecan [Carya illinoinensis (Wangenh.) K. Koch].The plant genome · 2026Article
- A high-recovery, high-density targeted genotyping platform for cranberry.The plant genome · 2026Article
- A public mid-density genotyping platform for cultivated cranberry (Vaccinium macrocarpon Aiton).The plant genome · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Cranberry (Vaccinium macrocarpon Aiton), a native North American fruit crop, has gained global popularity due to its unique flavor and health benefits. As the market expands for new cranberry products, the requirements to produce varieties that meet new standards have increased. DNA-assisted breeding in cranberry has been limited due to the lack of cost-effective genotyping tools. To address this gap, Breeding Insight developed and validated a 3K DArTag panel. Target loci were strategically selected from 507K single-nucleotide polymorphisms (SNPs), generated from resequencing 53 diverse cultivated cranberry accessions. Selection criteria prioritized even genomic distribution, genic regions, maximum genetic diversity among North American breeding germplasm, and markers associated with known quantitative trait loci. The cranberry 3K DArTag panel was validated using a diverse collection of cranberry accessions, interspecific hybrids, and two F
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.